Frequency of human CYP2D6 mutant alleles in a normal Chinese population.
Open Access
- 1 June 1994
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 37 (6), 605-607
- https://doi.org/10.1111/j.1365-2125.1994.tb04311.x
Abstract
Substantial differences in the pharmacogenetics of debrisoquine hydroxylation exist between Caucasians and Chinese populations. Among Chinese, not only is the frequency of the poor metabolizer phenotype low, the contribution of the 29B mutation in the CYP2D6 gene is insignificant. By contrast the frequency of D6-J is very common (approximately 0.6) and is clearly related to the activity of debrisoquine hydroxylase. Its presence however, does not predict the poor metabolizer phenotype. The D6-C mutation was also not detectable in our population.Keywords
This publication has 16 references indexed in Scilit:
- Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolismPharmacogenetics, 1993
- Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotypePharmacogenetics, 1991
- Distinct phenotypes and genotypes of debrisoquine hydroxylation among Europeans and Chinese [letter]British Journal of Clinical Pharmacology, 1991
- Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplificationThe Lancet, 1990
- DISASSOCIATION BETWEEN DEBRISOQUINE HYDROXYLATION PHENOTYPE AND GENOTYPE AMONG CHINESEThe Lancet, 1989
- OXIDATION PHENOTYPING IN CHINESE AND MALAY POPULATIONSClinical and Experimental Pharmacology and Physiology, 1988
- Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Measurement of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1987
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979